Preventing Alzheimer's

at 10:00 AM
 (Sebastien Bozon/AFP/Getty Images)

A new trial of an Alzheimer's drug will test whether it can prevent the onset of the disease in people who are genetically predisposed to get it. If the drug is successful, there is hope -- but no guarantee -- that it could prevent Alzheimer's among the general public. We discuss the trial and its possible implications.

Guests:

Geoffrey Kerchner, assistant professor of neurology at the Stanford School of Medicine

Eric Reiman, CEO of Banner Research and executive director of Banner Alzheimer's Institute, a nonprofit dedicated to preventing Alzheimer's that is one of the study's leaders

William Fisher, CEO of the Alzheimer's Association of Northern California and Northern Nevada

Sponsored

Sponsored

Volume
KQED Live
Live Stream
LATEST NEWSCAST
KQED
NPR
Live Stream information currently unavailable.
Share
LATEST NEWSCAST
KQED
NPR
KQED Live

Live Stream

Live Stream information currently unavailable.